Kyle brings deep experience in financial due diligence and transaction advisory, having guided provider organizations and healthcare‑focused investors through complex acquisitions, divestitures, and investment decisions for nearly 10 years. He helps clients evaluate transaction risk, assess earnings sustainability, and make informed capital allocation decisions by translating complex financial analysis into clear, actionable insights.
Kyle's work focuses on providing transaction support and financial analysis for healthcare organizations and investors pursuing acquisitions, divestitures, and strategic partnerships. He has supported numerous buy‑side and sell‑side due diligence engagements across the healthcare services landscape, including multisite provider platforms, specialty care organizations, pharmaceutical and life sciences businesses, and post‑acute and home‑based care providers. These engagements span transaction values ranging from approximately $30 million to more than $5 billion and include minority investments, platform acquisitions, and complex carve‑outs. His findings frequently inform valuation discussions, purchase agreement negotiations, and investment committee decision‑making, generating key data that enables clients to validate investment theses, identify key risks and value drivers, and execute transactions with greater clarity and confidence.
